A detailed history of Nisa Investment Advisors, LLC transactions in Cor Medix Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 123 shares of CRMD stock, worth $1,270. This represents 0.0% of its overall portfolio holdings.

Number of Shares
123
Previous 123 -0.0%
Holding current value
$1,270
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

BUY
$4.08 - $6.39 $501 - $785
123 New
123 $0
Q1 2022

Apr 29, 2022

SELL
$3.83 - $6.24 $28,395 - $46,263
-7,414 Closed
0 $0
Q4 2021

Feb 03, 2022

BUY
$4.47 - $5.56 $33,140 - $41,221
7,414 New
7,414 $31,000

Others Institutions Holding CRMD

About CorMedix Inc.


  • Ticker CRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,208,200
  • Market Cap $426M
  • Description
  • CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...
More about CRMD
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.